Direkt zum Inhalt
Merck
Alle Fotos(4)

Dokumente

L9664

Sigma-Aldrich

Loratadin

≥98% (HPLC), powder

Synonym(e):

4-(8-Chlor-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yliden-1-piperidincarbonsäure-ethylester

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(4)

About This Item

Empirische Formel (Hill-System):
C22H23N2O2Cl
CAS-Nummer:
79794-75-5
Molekulargewicht:
382.88
MDL-Nummer:
MFCD00672869
UNSPSC-Code:
12352200
PubChem Substanz-ID:
24278525
NACRES:
NA.77

Qualitätsniveau

200

Assay

≥98% (HPLC)

Form

powder

Farbe

white

Löslichkeit

DMSO: soluble 50 mg/mL
H2O: insoluble

Ersteller

Schering Plough

Lagertemp.

2-8°C

SMILES String

CCOC(=O)N1CC\C(CC1)=C2/c3ccc(Cl)cc3CCc4cccnc24

InChI

1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3

InChIKey

JCCNYMKQOSZNPW-UHFFFAOYSA-N

Angaben zum Gen

human ... CYP3A4(1576) , HRH1(3269) , KCNH1(3756) , KCNH2(3757) , PTAFR(5724)
rat ... Hrh1(24448)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Biochem./physiol. Wirkung

Nichtsedierender Histamin H1-Rezeptorantagonist.
Loratadine is a non-sedating histamine H1-receptor antagonist. Shown to inhibit the two-pore domain potassium channel K2P18.1 (also called TRESK or KCNK18).

Leistungsmerkmale und Vorteile

This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

D1069

Desloratadin, powder, ≥98% (HPLC)

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 10

1 of 10

Rupatadine

Sigma-Aldrich

CDS022916

Rupatadine

vibrant-m

Y0000604

Loratadin Unreinheit F

Desloratadin United States Pharmacopeia (USP) Reference Standard

USP

1173042

Desloratadin

Cyproheptadin -hydrochlorid United States Pharmacopeia (USP) Reference Standard

USP

1161000

Cyproheptadin -hydrochlorid

Desloratidin Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1680

Desloratidin

Domperidon powder, ≥98% (HPLC)

Sigma-Aldrich

D122

Domperidon

Cetirizin -dihydrochlorid ≥98% (HPLC)

Sigma-Aldrich

C3618

Cetirizin -dihydrochlorid

Levocetirizin -dihydrochlorid ≥98% (HPLC)

Sigma-Aldrich

L7795

Levocetirizin -dihydrochlorid

Amikacin -sulfat European Pharmacopoeia (EP) Reference Standard

A0365900

Amikacin -sulfat

Loperamid -hydrochlorid

Sigma-Aldrich

L4762

Loperamid -hydrochlorid

F M Baroody et al.
Allergy, 55 Suppl 64, 17-27 (2001-04-09)
The primary mechanism of antihistamine action in the treatment of allergic diseases is believed to be competitive antagonism of histamine binding to cellular receptors (specifically, the H1-receptors), which are present on nerve endings, smooth muscles, and glandular cells. This notion
Karsten Weller et al.
Acta dermato-venereologica, 93(2), 168-174 (2012-10-12)
Non-sedating H1-antihistamines are the recommended first-line treatment for chronic spontaneous urticaria. While efficacy studies usually apply continuous daily treatment regimens, many patients take their medication on demand. In this randomized, double-blind trial we tested whether on-demand H1-antihistamine desloratadine in standard
P Deep et al.
Synapse (New York, N.Y.), 34(4), 313-318 (1999-10-26)
The efficacy of amantadine in alleviating motor symptoms of Parkinson's disease may be mediated in part by stimulation of cerebral dopa decarboxylase (DDC) activity, secondary to antagonism of N-methyl-D-aspartate (NMDA) type glutamate receptors. We tested the specific hypothesis that amantadine
F Estelle R Simons et al.
The Journal of allergy and clinical immunology, 110(5), 777-783 (2002-11-06)
The extent of the distribution of H(1)- antihistamines into the skin and H(1)-antihistamine activity in the skin are clinically relevant in the treatment of allergic skin disorders. In a prospective, randomized, double-blind, parallel-group, multiple-dose study, we gave fexofenadine 180 mg
M Magerl et al.
The British journal of dermatology, 166(5), 1095-1099 (2012-01-17)
Cold urticaria is a rare but severe and potentially lethal condition. It is primarily treated symptomatically with H(1) -antihistamines. However, patients have a variable response to these drugs and, to date, it has not been possible to predict readily the
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.